Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...

It became clear over the first quarter that the amount of business that had gone to the compounders was just significantly ...

Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

Russian President Vladimir Putin and Venezuelan President Nicolas Maduro on Wednesday signed a strategic partnership ...

The National Institutes of Health and the Centers for Medicare & Medicaid Services have partnered to enable research around ...

As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the ...

Shares of Novo Nordisk (NVO) jumped 5% in pre-market trading on Tuesday after its first-quarter earnings beat estimates but ...

Ford Motor is hiking prices on three of its Mexico-produced models effective May 2, becoming one of the first major ...

India's central bank on Wednesday laid down a framework to standardise the process of making and amending rules, including ...

Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due what Novo says is illegal compounding of GLP-1 ...

Telecom Italia (TIM) on Wednesday posted a 5.4% rise in its core earnings in the first quarter but debt at Italy's biggest telecoms group edged up as cash generation was negative in the period.